RELATIONSHIP OF DIABETES MELLITUS TYPE II TO DEPRESSION AND TREATMENT WITH ANTIDEPRESSANTS
DOI:
https://doi.org/10.5281/zenodo.4275851Keywords:
Diabetes Mellitus. Depression. Chronic Diseases.Abstract
The association between type 2 diabetes mellitus (DM2) and the presence of depression has been presented in the literature by several authors, the apparent symptoms related to hyperglycemia, such as excessive tiredness and weakness may have positive points for the onset of depressive symptoms, as well as responsibility for treatment, dietary restrictions and adverse effects in the use of antidepressant drugs. Among those that stand out as risk factors commonly associated with the development of depressive symptoms in patients with diabetes are: age, obesity, as well as the increase in the amount of drugs in use, such as antidepressants. Thus, this study is a systematic review, and seeks to better understand the relationship between diabetes mellitus and depression and the possible implications of the use of antidepressants on metabolic changes, specifically, glycemic level. Through the analyzed articles, it can be considered that there is a relationship between diabetes mellitus and an increase in clinical depressive symptoms. This relationship covers both metabolic control and adaptive aspects, such as socioeconomic factors, non-acceptance of the disease, low educational level, lifestyle, family history. Antidepressants of the selective serotonin reuptake inhibitor (SSRI) class have been shown to have a positive effect on the treatment of depression in patients with DM2. The most studied antidepressants in this class were Sertraline and Fluoxetine and they were effective in treating depression and improving glycemic control.
Downloads
References
Li C, Ford ES, Strine TW, Mokdad AH. Prevalence of depression among U.S. adults with diabetes: findings from the 2006 behavioral risk factor surveillance system. Diabetes Care 2008; 31:105–7. doi:10.2337/dc07-1154.
Roy T, Lloyd CE. Epidemiology of depression and diabetes: A systematic review. J Affect Disord 2012;142:S8–21.
Nouwen A, Winkley K, Twisk J, Lloyd CE, Peyrot M, Ismail K, et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia 2010; 53:2480–6. doi:10.1007/s00125-010-1874-x.
Lustman PJ, Freedland KE, Griffith LS, Clouse RE. Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care 2000; 23:618–23.
Gonzalez JS, Safren SA, Cagliero E, Wexler DJ, Delahanty L, Wittenberg E, et al. Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity. Diabetes Care 2007; 30:2222–7.
de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001; 63:619–30.
Pan A, Lucas M, Sun Q, van Dam RM, Franco OH, Willett WC, et al. Increased Mortality Risk in Women with Depression and Diabetes Mellitus. Arch Gen Psychiatry 2011; 68:42.
Scherrer JF, Garfield LD, Chrusciel T, Hauptman PJ, Carney RM, Freedland KE, et al. Increased risk of myocardial infarction in depressed patients with type 2 diabetes. Diabetes Care 2011; 34:1729–34. doi:10.2337/dc11-0031.
Hutter N, Scheidt-Nave C, Baumeister H. Health care utilisation and quality of life in individuals with diabetes and comorbid mental disorders. Gen Hosp Psychiatry 2009; 31:33–5.
Das R, Singh O, Thakurta RG, Khandakar MR, Ali SN, Mallick AK, et al. Prevalence of Depression in Patients with Type II Diabetes Mellitus and its Impact on Quality of Life. Indian J Psychol Med 2013; 35:284–9.
Raval A, Dhanaraj E, Bhansali A, Grover S, Tiwari P. Prevalence & determinants of depression in type 2 diabetes patients in a tertiary care centre. Indian J Med Res 2010; 132:195–200.
Rotella F, Mannucci E. Diabetes mellitus as a risk factor for depression. A meta-analysis of longitudinal studies. Diabetes Res Clin Pract 2013; 99:98–104.
Nouwen A, Winkley K, Twisk J, Lloyd CE, Peyrot M, Ismail K, et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia 2010; 53:2480–6. doi:10.1007/s00125-010-1874-x.
Champaneri S, Wand GS, Malhotra SS, Casagrande SS, Golden SH. Biological Basis of Depression in Adults with Diabetes. Curr Diab Rep 2010; 10:396–405.
Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron 2002; 34:13–25.
Dalzochio, T., Bonho, L., Feksa, L. e Berlese, D. Uma ligação entre depressão e diabete mellitus. Revista de ciências médicas, 23, 91-99, 2014.
Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature. 455(7215):894-902.16 Oct 2008.
Harvey BH. Is major depressive disorder a metabolic encephalopathy? Hum Psychopharmacol. (5): 371-84 Jul; 23 2008.
Colunga-Rodríguez, C., García, J., Salazar-Estrada, J. y Angel-González, M. Diabetes tipo 2 y depresión en Guadalajara, México. 2005. Revista salud pública, 10(1), 137-149 2008.
Frokjaer VG, Vinberg M, Erritzoe D, Svarer C, Baare W, Budtz-Joergensen E, et al. High familial risk for mood disorder is associated with low dorsolateral prefrontal cortex serotonin transporter binding. Neuroimage. (2):360-6. Jun; 46 2009.
Brasil. Saúde Brasil 2010: uma análise da situação de saúde e da agenda nacional e internacional de prioridades em saúde. Brasília, 2011.
Frokjaer VG, Mortensen EL, Nielsen FA, Haugbol S, Pinborg LH, Adams KH, et al. Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder. Biol Psychiatry. 63(6):569 76. 15; Mar 2008.
Maletic V, Robinson M, Oakes T, Iyengar S, Ball SG, J. R. Neurobiology of depression: an integrated view of key findings. IntJ Clin Pract.; 61(12):2030 – 40 2007.
Frodl T, Reinhold E, Koutsouleris N, Donohoe G, Bondy B, Reiser M, et al. Childhood stress, serotonin transporter gene and brain structures in major depression. Neuropsychopharmacology. (6): 1383-90. 35; May 2010.
Van TM, Mccasckill CC, Lane JD. Depressed mood is a factor in glycemic control intype 1 diabetes. Psychosom Med. 63:551-5.; 2001.
Ministério da Saúde (BR), Secretaria de Políticas de saúde. Diabete (diabetes mellitus): sintomas causas e tratamentos. Brasília (DF); 2020.
Sociedade Brasileira de Diabetes (SBD). Algoritmo para o tratamento do diabetes tipo 2 – atualização 2011. Posicionamento oficial SBD número 3 – 2011. Disponível em: http://www.diabetes.org.br/attachments/posicionamento/posicionamentosbd-n-03-2011.pdf.
International Diabetes Federation. IDF Diabetes Atlas update poster. 7 th ed. Brussels: International Diabetes Federation, 2015.
Guariguata, L.; Whinting, D. R.; Hambleton, I.; Beagley, J.; linnenkamp, U.; Shaw, J. E. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Research and Clinical Practice, v. 103, no. 2, p. 137–149, Feb. 2014.
Corrêa K, Gouvêa GR, Silva MAV, Possobon RF, Barbosa LFLN, Pereira AC et al. Qualidade de vida e características dos pacientes diabéticos; Faculdade de Odontologia de Piracicaba, Unicamp. Av. Limeira 901, Areião. 13414- 903 Piracicaba SP Brasil; 2015-2016.
Brasil. Saúde Brasil 2010: uma análise da situação de saúde e da agenda nacional e internacional de prioridades em saúde. Brasília, 2011.
Kessler RC, McGonagle K a, Swartz M, Blazer DG, Nelson CB. Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence. J Affect Disord. 1993;29(2-3):85-96. doi:10.1016/0165-0327(93)90026- G.
Perturbações, DSM-V Man Diagnóstico e Estatística das Perturbações Mentais -Am Psychiatr Assoc Climepsi Ed. 2014.
H. P. Rang, J. M. Ritter, R. J. Flower, G. Henderson. Rang&Dale Farmacologia. 8.ed. GEN Guanabara Koogan; 12 de janeiro de 2016.
Kessler, R. C.; Petukhova, M.; Sampson, N. A.: Zaslavsky, A. M.; Wittchen, H.-U. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. International Journal of Methods in Psychiatric Research, v. 21, no. 3, p. 169–184, Sept. 2012.
Baumeister, H.; Hutter, N.; Bengel, J. Psychological and pharmacological interventions for depression in patients with coronary artery disease. The Cochrane Database of Systematic Reviews, no. 9, p. CD008012, Jan. 2011.
Baumeister, H.; Hutter, N.; Bengel, J. Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depression. Cochrane Database of Systematic Reviews, no. 12, p. CD008381, 2012.
Hollister Le. Current antidepressant drugs: Their clinical use. Drugs, 1981, 22:129-152.
Lustman PJ, Giffith LS, Clouse RE, Freedland KE, Eisen AS, Rubin EH, et al. Effects nortriptyline on depression and glycemic control in diabetes: Results of a double-blind, placebo-controlled trial. Psychosom Med; 59:241-50. 1997.
Constantino-Cerna, A., Bocanegra-Malca, M., León-Jiménez, F., & Díaz-Velez, C. Frecuencia de depresión y ansiedad em patients for diabetes tipo 2 atendidos em un hospital general de Chiclayo. Revista médica herediana, 196-210, 25 (4) 2014.
Doyle, T., Halaris, A., & Rao, M. Percursos neurobiológicos compartilhados entre diabetes tipo 2 e sintomas depressivos: Uma revisão dos achados morfológicos e neurocognitivos. Relatórios atuais de diabetes, 14 (560), 2-12. doi: 10.1007 /s11892-014-0560-7, 2014.
Molina, A., Acevedo, O. Yáñez, M., Dávila, R. e González, A. Comparação das prevalências do duelo, depressão e qualidade de vida com a doença em pacientes com diabetes mellitus tipo 2 descontrolados y controlados. Revista de especialidades médico-quirúrgicas, 18 (1), 13-18,2013.
Lyketsos, Depressão e Diabetes: Mais sobre o que o relacionamento pode ser. O jornal americano de psiquiatria, 167 (5), 498-500, 2010.
Colunga-Rodríguez, C., García, J., Salazar-Estrada, J. y Angel-González, M. Diabetes tipo 2 y depresión en Guadalajara, México. 2005. Revista salud pública, 10(1), 137-149 2008.
Ministério da saúde, Diabetes mellitus; Caderno de Atenção Básica n0 36;2013.
Michels MJ, Depressão em diabéticos tipo 2: prevalência, fatores associados da aderência ao tratamento e complicações do diabetes, Universidade Federal de Santa Catarina, Programa de Pós-Graduação em Ciências Médicas;2010.
Katon, W.; Pedersen, H. S.; Ribe, A. R.; Fenger-Gron, M.; Davydow, D.; Waldorff, F B.; Vestergaard, M. Effect of Depression and Diabetes Mellitus on the Risk for Dementia. JAMA Psychiatry, v. 72, no. 6, p. 612, 2015.
Lin, E. H. B. et al. Mental disorders among persons with diabetes--results from the World Mental Health Surveys. Journal of Psychosomatic Research, v. 65, no. 6, p. 571–580, Dec. 2008.
Mezuk, B.; Eaton, W. W.; Albrecht, S.; Golden, S. H. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care, v. 31, no. 12, p. 2383–2390, Dec. 2008.
Nouwen, A.; Winkley, K.; Twisk, J.; Lloyd, C. E.; Peyrot, M.; Ismail, K.; Pouwer, F. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia, v. 53, no. 12, p. 2480–2480, Dec. 2010.
Renn, B. N.; Feliciano, L.; Segal, D. L. The bidirectional relationship of depression and diabetes: A systematic review. Clinical Psychology Review, v. 31, no. 8, p. 1239–1246, 2011.
Darnall BD, Suarez EC. Sex and gender in psychoneuroimmunology research: past, present and future. Brain Behav Immun. 2009; 23:595–604. [PMC free article] [PubMed] [Google Scholar].
Mikolajczyk, R. T.; EL Ansari, W.; Maxuell, A. E. Food consumption frequency and perceived stress and depressive symptoms among students in three European countries. Nutrition Journal, v. 8, no. 1, p. 31, 2009.
Knol, M. J.; Twisk, J. W. R.; Beekman, A. T. F.; Heine R. J.; Snoek, F. J.; Pouwer, F. Depression as a risk factor for the onset of type 2 diabetes mellitus. a meta-analysis. Diabetologia, v. 49, no. 5, p. 837–845, May 2006.
Rotella, F.; Mannucci, E. Diabetes mellitus as a risk factor for depression. A meta-analysis of longitudinal studies. Diabetes Research and Clinical Practice, v. 99, no. 2, p.98–104, 2013.
Raval, A.; Dhanaraj, E.; Bhansali, A.; Grover, S.; Tiwari, P. Prevalence & determinants of depression in type 2 diabetes patients in a tertiary care centre. The Indian Journal of Medical Research, v. 132, p. 195–200, Aug. 2010.
Bonfim, Antonio Joaquim. Associação entre a presença de diabetes mellitus tipo 2 e sintomas depressivos: estudo observacional sobre o tratamento com antidepressivos e as alterações metabólicas. Maringá, 2016.
Gois C, Dias V V, Carmo I, et al. Treatment response in type 2 diabetes patients with major depression. Clin Psychol Psychother. 2014;21(1):39-48. doi: http://dx.doi.org/10.1002/cpp.1817.
